<DOC>
	<DOCNO>NCT02363127</DOCNO>
	<brief_summary>Randomised , prospective , investigator-blinded , control , single-centre study assess impact ongoing pregnancy rate use two progesterone different administration route , recipient fresh embryo donor oocyte , undergo endometrial preparation fresh embryo transfer .</brief_summary>
	<brief_title>Subcutaneous Progesterone Versus Vaginal Progesterone Endometrial Preparation Fresh Donated Oocytes Recipients</brief_title>
	<detailed_description>Exploratory study control group treat accord Service 's usual therapeutic regimen transfer embryos donor oocyte . The controlled ovarian stimulation protocol oocyte donor always calculate accord standard protocol Bernabeu Institute . Endometrial preparation carry follow standard protocol Bernabeu Institute follow : oestrogen administer transdermally patient maintain ovarian function undergo medical hypophysectomy depot GnRH agonists administer mid-luteal phase previous cycle . On day oocyte retrieval , patient randomise : Group A administer subcutaneous progesterone 25 mg/day ( Prolutex ) , Group B administer vaginal progesterone capsule 200 mg/3 time day ( Progeffik ) . The embryo transfer perform day 5 embryo culture ( Day +5 ) . A biochemical pregnancy test beta- hCG P4 analysis perform 14 day oocyte retrieval . All cycle monitor accord Department 's standard criterion , use transvaginal ultrasound ass embryonic development endometrial thickness , well analytical control . The study blind investigator . The evaluate professional know subject administer vaginal progesterone subcutaneous progesterone . The medication deliver person participate evaluation dedicate group assignment , data centralisation , deliver medication . The aim study determine ongoing pregnancy rate patient undergo fresh embryo transfer cycle donor oocyte affect progesterone administration route .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Female , age 18 49 year ( inclusive ) Woman wish become pregnant Endometrial thickness great 7 mm day patient randomisation one progesterone group Six donor retrieve oocyte Patient program fresh embryo transfer day +5 embryo culture BMI low 30 Kg/m2 Infertility justify treatment donor oocytes Male know karyotype alteration Semen ejaculation either partner bank Uterus able support embryo implantation pregnancy Absence pregnancy start embryo transfer cycle Has give prior write consent Important systemic disease , endocrinemetabolic abnormality involve pituitary , thyroid , adrenal , pancreas , liver kidney . HIV , HBV HCV seropositivity Undiagnosed vaginal bleeding Pregnancy , breastfeed contraindication become pregnant Malformation sexual organ incompatible pregnancy Known allergy progesterone preparation excipients Current dependence alcohol , drug psychotropic medication Concurrent participation another study Concomitant medication could interfere study medication : different hormonal treatment use study , except thyroid hormone , antipsychotic , anxiolytic , hypnotic , sedative , chronic treatment prostaglandin inhibitor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Reproductive Techniques</keyword>
	<keyword>Infertility</keyword>
	<keyword>Reproductive Techniques Assisted</keyword>
</DOC>